Form 8-K - Current report:
SEC Accession No. 0000950142-25-002625
Filing Date
2025-10-01
Accepted
2025-10-01 16:31:51
Documents
16
Period of Report
2025-09-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh250683952_8k.htm   iXBRL 8-K 41420
2 EXHIBIT 99.1 eh250683952_ex9901.htm EX-99.1 613428
3 EXHIBIT 99.2 eh250683952_ex9902.htm EX-99.2 1086025
4 EXHIBIT 99.3 eh250683952_ex9903.htm EX-99.3 612960
5 EXHIBIT 99.4 eh250683952_ex9904.htm EX-99.4 1084836
  Complete submission text file 0000950142-25-002625.txt   4322313

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE na-20250925.xsd EX-101.SCH 2993
7 XBRL LABEL FILE na-20250925_lab.xml EX-101.LAB 34915
8 XBRL PRESENTATION FILE na-20250925_pre.xml EX-101.PRE 22776
18 EXTRACTED XBRL INSTANCE DOCUMENT eh250683952_8k_htm.xml XML 3514
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
Chrome Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 251365057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)